Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Zillow Group, Inc., a digital real estate company, operates real estate brands on mobile applications and Websites in the United States. The company operates through three segments: Homes; Internet, Media & Technology; and Mortgages. The Homes segment is involved in resale of homes; and title and escrow services to home buyers and sellers, including title search procedures for title insurance policies, escrow, and other closing services. The IMT segment offers premier agent, rentals, and new construction marketplaces, as well as dotloop, display, and other advertising, as well as business software solutions. The Mortgage segment provides home loans; and marketing products including custom quote and connect services. Its portfolio of brands includes Zillow Rentals, Trulia, StreetEasy, Zillow Closing Services, HotPads, and Out East. The company was incorporated in 2004 and is headquartered in Seattle, Washington.

Zillow Group, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

NEW YORK, MAY 12, 2026 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ZILLOW GROUP, INC. (ZILLOW OR THE COMPANY) (NASDAQ: Z). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COM OR 646-581-9980, EXT.7980.

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ZILLOW GROUP, INC. - Z

NEW YORK, MAY 10, 2026 (GLOBE NEWSWIRE) -- WHY:ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZILLOW GROUP, INC. (NASDAQ: Z, ZG) RESULTING FROM ALLEGATIONS THAT ZILLOW MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.

Z INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ZILLOW GROUP, INC. (NASDAQ: Z, ZG), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

NEW YORK, MAY 7, 2026 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ZILLOW GROUP, INC. ("ZILLOW" OR THE "COMPANY") (NASDAQ: Z). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COMOR 646-581-9980, EXT.

NEW YORK, MAY 06, 2026 (GLOBE NEWSWIRE) -- WHY:ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZILLOW GROUP, INC. (NASDAQ: Z, ZG) RESULTING FROM ALLEGATIONS THAT ZILLOW MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.

SEATTLE, MAY 6, 2026 /PRNEWSWIRE/ -- ZILLOW GROUP, INC. (NASDAQ: Z AND ZG), WHICH IS TRANSFORMING THE WAY PEOPLE BUY, SELL, RENT AND FINANCE HOMES, TODAY ANNOUNCED ITS CONSOLIDATED FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2026. COMPLETE FINANCIAL RESULTS FOR THE FIRST QUARTER AND OUTLOOK FOR THE SECOND QUARTER AND THE FULL YEAR OF 2026 CAN BE FOUND IN THE SHAREHOLDER LETTER ON THE INVESTOR RELATIONS SECTION OF ZILLOW GROUP'S WEBSITE AT HTTPS://INVESTORS.ZILLOWGROUP.COM/INVESTORS/FINANCIALS/QUARTERLY-RESULTS/DEFAULT.ASPX.

ZILLOW GROUP REPORTS FIRST-QUARTER 2026 FINANCIAL RESULTS

NEW LISTINGS GREW FASTER THAN SALES FOR THE FIRST TIME THIS YEAR SEATTLE, MAY 6, 2026 /PRNEWSWIRE/ -- HOUSING INVENTORY IS BUILDING WHILE BUYER DEMAND REVERTED TO A MORE CAUTIOUS STANCE RELATIVE TO MARCH. FOR THE FIRST TIME IN 2026, NEW LISTINGS GREW MORE ON AN ANNUAL BASIS THAN HOME SALES DID, ACCORDING TO THE ZILLOW APRIL MARKET REPORT.

HIGHER RATES STALLED THE SALES RECOVERY, ZILLOW'S APRIL MARKET REPORT SHOWS

DESIGNATION EXPANDS (Z)-ENDOXIFEN PROGRAM INTO RARE PEDIATRIC ENDOCRINE DISORDER AND QUALIFIES ATOSSA FOR A PRIORITY REVIEW VOUCHER AWARD UPON APPROVAL SEATTLE, MAY 4, 2026 /PRNEWSWIRE/ -- ATOSSA THERAPEUTICS, INC. (NASDAQ: ATOS) ("ATOSSA" OR THE "COMPANY"), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY DEVELOPING NOVEL THERAPIES IN ONCOLOGY AND OTHER AREAS OF HIGH UNMET CLINICAL NEED, TODAY ANNOUNCED THAT THE U.S. FOOD AND DRUG ADMINISTRATION ("FDA") HAS GRANTED RARE PEDIATRIC DISEASE ("RPD") DESIGNATION TO (Z)-ENDOXIFEN FOR THE TREATMENT OF MCCUNE-ALBRIGHT SYNDROME ("MAS") IN FEMALES. RPD DESIGNATION IS GRANTED TO DRUG CANDIDATES INTENDED TO TREAT SERIOUS OR LIFE-THREATENING DISEASES THAT PRIMARILY AFFECT INDIVIDUALS FROM BIRTH TO 18 YEARS OF AGE.

ATOSSA THERAPEUTICS RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR (Z)-ENDOXIFEN FOR MCCUNE-ALBRIGHT SYNDROME

NEW YORK, MAY 03, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZILLOW GROUP, INC. (NASDAQ: Z, ZG) RESULTING FROM ALLEGATIONS THAT ZILLOW MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.

NEW YORK, APRIL 30, 2026 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ZILLOW GROUP, INC. ("ZILLOW" OR THE "COMPANY") (NASDAQ: Z). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COMOR 646-581-9980, EXT.

NEW YORK, APRIL 30, 2026 (GLOBE NEWSWIRE) -- WHY:ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZILLOW GROUP, INC. (NASDAQ: Z, ZG) RESULTING FROM ALLEGATIONS THAT ZILLOW MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.

NEW YORK, APRIL 28, 2026 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ZILLOW GROUP, INC. (ZILLOW OR THE COMPANY) (NASDAQ: Z). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COMOR 646-581-9980, EXT.7980.

NEW YORK, APRIL 26, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZILLOW GROUP, INC. (NASDAQ: Z, ZG) RESULTING FROM ALLEGATIONS THAT ZILLOW GROUP, INC. MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.

ZILLOW INVESTOR NEWS: IF YOU HAVE SUFFERED LOSSES IN ZILLOW GROUP, INC. (NASDAQ: Z, ZG), YOU ARE ENCOURAGED TO CONTACT THE ROSEN LAW FIRM ABOUT YOUR RIGHTS

NEW YORK, APRIL 23, 2026 (GLOBE NEWSWIRE) -- WHY:ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZILLOW GROUP, INC. (NASDAQ: Z, ZG) RESULTING FROM ALLEGATIONS THAT ZILLOW MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.

HOMES THAT SELL WITHIN SEVEN DAYS ARE 2.6 TIMES MORE LIKELY TO SELL ABOVE ASKING PRICE NATIONALLY, 18.5% OF HOMES WENT PENDING WITHIN SEVEN DAYS IN FEBRUARY 2026, ACCORDING TO A ZILLOW ANALYSIS. IN THE FASTEST MARKETS  ST. LOUIS, HARTFORD AND SEATTLE  MORE THAN 1 IN 3 HOMES SOLD THAT QUICKLY.

GONE IN 7 DAYS: ONE-THIRD OF HOMES SELL WITHIN A WEEK IN THE FASTEST MARKETS, WHILE OTHERS SIT

NEW YORK, APRIL 21, 2026 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ZILLOW GROUP, INC. (ZILLOW OR THE COMPANY) (NASDAQ: Z). SUCH INVESTORS ARE ADVISED TO CONTACT DANIELLE PEYTON AT NEWACTION@POMLAW.COMOR 646-581-9980, EXT.7980.

INCOMES ARE RISING FASTER THAN RENTS NATIONWIDE, PUTTING AN EXTRA $193 A MONTH BACK IN RENTERS' POCKETS THE TYPICAL U.S. ASKING RENT WAS $1,910 IN MARCH, UP 1.8% YEAR OVER YEAR, ACCORDING TO THE ZILLOW OBSERVED RENT INDEX (ZORI). THAT IS THE SLOWEST ANNUAL PACE SINCE 2020.

RENTERS GAIN OVER $2,300 IN RELIEF AS RENT GROWTH HITS SLOWEST PACE SINCE 2020

NEW YORK, APRIL 20, 2026 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZILLOW GROUP, INC. (NASDAQ: Z, ZG) RESULTING FROM ALLEGATIONS THAT ZILLOW GROUP, INC. MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.

EXPOSED BEAMS AND STORYBOOK TUDORS: ZILLOW DATA SHOWS CHARACTER-FILLED HOMES CAPTURE HEARTS AND CLICKS FOR-SALE LISTINGS WITH EXPOSED BEAMS ARE SEEING A 20% BOOST IN DAILY BUYER ENGAGEMENT ON ZILLOW, WHILE OTHER VINTAGE ARCHITECTURAL FEATURES, SUCH AS BRICK WALLS AND ARCHED DOORWAYS, ARE ALSO DRIVING BUYER BUZZ. VICTORIAN, TUDOR AND MIDCENTURY HOMES ARE DRAWING AT LEAST 13% MORE BUYER INTEREST ON ZILLOW.

THE ZILLOW BUZZ INDEX REVEALS THE HOME FEATURES BUYERS CAN'T RESIST RIGHT NOW

IMPROVING AFFORDABILITY AND RISING INVENTORY ARE EASING THE PATH TO HOMEOWNERSHIP IN MARKETS ACROSS THE SUN BELT AND MIDWEST JACKSONVILLE RANKS NO. 1 AMONG THE 50 LARGEST U.S. METROS FOR FIRST-TIME BUYERS, FOLLOWED BY BIRMINGHAM, SAN ANTONIO, ATLANTA AND HOUSTON.

ZILLOW NAMES JACKSONVILLE THE BEST MARKET FOR FIRST-TIME BUYERS THIS SPRING

24 ADDITIONAL FIRMS SIGN AGREEMENTS, ACCELERATING SHIFT TOWARD OPEN, PUBLIC PRE-MARKET LISTINGS ON ZILLOW AND TRULIA SEATTLE, MARCH 25, 2026 /PRNEWSWIRE/ -- ONE WEEK AFTER INTRODUCING ZILLOW PREVIEW , ZILLOW IS ALREADY SEEING STRONG INDUSTRY MOMENTUM WITH 24 ADDITIONAL BROKERAGES SIGNING ON TO BRING PREMARKET HOME LISTINGS INTO THE OPEN ON ZILLOW AND TRULIA. THESE BROKERAGES ARE PARTNERING WITH ZILLOW TO EXPAND EARLY VISIBILITY FOR SELLERS, AGENTS AND BUYERS AT A CRITICAL MOMENT IN THE HOME SHOPPING JOURNEY.

ZILLOW PREVIEW GAINS RAPID MOMENTUM AS DOZENS OF NEW BROKERAGES SIGN ON

BUILT INTO ZILLOW'S PLATFORM, IT CONNECTS LIVE LISTINGS DATA ACROSS FOR-SALE AND RENTAL HOMES WITH PERSONALIZED, REAL-WORLD ACTIONS SUCH AS TOUR SCHEDULING AND CONNECTING WITH AN AGENT SEATTLE, MARCH 25, 2026 /PRNEWSWIRE/ -- ZILLOW TODAY ANNOUNCED ZILLOW AI MODE, A NEW EXPERIENCE THAT HELPS BUYERS AND RENTERS DISCOVER HOMES THROUGH CONVERSATION, RECEIVE GUIDANCE AND TAKE REAL STEPS SUCH AS SCHEDULING TOURS OR CONNECTING WITH A LOCAL AGENT. THIS NEW WAY TOZILLOW IS DESIGNED FOR ANYONE EXPLORING HOUSING  FROM DREAMERS BROWSING LATE AT NIGHT TO RENTERS COMPARING TRADEOFFS BETWEEN APARTMENT BUILDINGS, BUYERS EXPLORING FINANCING, AND SELLERS PLANNING THEIR NEXT MOVE.

ZILLOW DEBUTS AI MODE, BRINGING GUIDED INTELLIGENCE TO EVERY STEP OF THE HOUSING JOURNEY

MULTIYEAR PARTNERSHIP PUTS ZILLOW TO THE FULL MLB SEASON, INCLUDING TENTPOLE MOMENTS AND THE POSTSEASON SEATTLE, MARCH 23, 2026 /PRNEWSWIRE/ -- ZILLOW IS STEPPING UP TO THE PLATE. THE COMPANY TODAY ANNOUNCED A MULTIYEAR PARTNERSHIP WITH MAJOR LEAGUE BASEBALL (MLB), BECOMING THE OFFICIAL REAL ESTATE AND HOME RENTALS MARKETPLACE PARTNER OF MLB.

ZILLOW BECOMES OFFICIAL PARTNER OF MAJOR LEAGUE BASEBALL, BRINGING 'HOME' TO AMERICA'S NATIONAL PASTIME

KELLER WILLIAMS, REMAX, HOMESERVICES OF AMERICA, SIDE AND UNITED REAL ESTATE ANNOUNCE PARTICIPATION IN NEW PUBLIC MARKETING OPTION ON ZILLOW SEATTLE, MARCH 17, 2026 /PRNEWSWIRE/ --ZILLOW GROUP, INC. (NASDAQ: Z AND ZG) TODAY ANNOUNCED ZILLOW PREVIEWSM, A NEW PRODUCT THAT BRINGS PRE-MARKET HOME LISTINGS INTO THE OPEN BY MAKING THEM PUBLICLY VISIBLE ON ZILLOW AND TRULIA. AT A TIME WHEN SOME REAL ESTATE BROKERAGES ARE HARMING CONSUMERS BY HIDING LISTINGS IN PRIVATE NETWORKS, ZILLOW PREVIEW ALLOWS BROKERAGES TO BROADLY SHARE LISTINGS BEFORE THEY HIT THE ACTIVE MARKET SO CONSUMERS CAN ACCESS THEM.

ZILLOW LAUNCHES ZILLOW PREVIEW TO BRING PRE-MARKET HOME LISTINGS INTO THE OPEN

STUDY HIGHLIGHTS FINDINGS THAT (Z)-ENDOXIFEN RESTORES MUSCLE PERFORMANCE AND LOWERS DAMAGE BIOMARKERS IN MDX5CV DYSTROPHIC MICE SEATTLE, MARCH 12, 2026 /PRNEWSWIRE/ -- ATOSSA THERAPEUTICS, INC. (NASDAQ: ATOS) ("ATOSSA" OR THE "COMPANY"), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY DEVELOPING NOVEL THERAPIES IN ONCOLOGY AND OTHER RARE DISEASE INDICATIONS WITH SIGNIFICANT UNMET NEED, PRESENTED AN ORAL CLINICAL TRIAL UPDATE ON (Z)-ENDOXIFEN AT THE MDA CLINICAL & SCIENTIFIC CONFERENCE ON MARCH 11, 2026, IN ORLANDO, FL. PRESENTATION HIGHLIGHTS THE MDX5CV DYSTROPHIC MOUSE MODEL, A TRUSTED, REPRODUCIBLE STANDARD FOR DUCHENNE MUSCULAR DYSTROPHY (DMD) PRECLINICAL RESEARCH, WAS USED FOR THIS STUDY (Z)-ENDOXIFEN IMPROVED MUSCLE STRENGTH AND MOTOR PERFORMANCE IN BOTH JUVENILE AND ADULT DYSTROPHIC MICE TREATMENT ENHANCED RESISTANCE TO CONTRACTION-INDUCED MUSCLE INJURY FAVORABLE CHANGES WERE OBSERVED IN BODY COMPOSITION, INCLUDING INCREASED LEAN MASS AND REDUCED FAT MASS KEY BIOCHEMICAL AND HISTOLOGIC MARKERS OF MUSCLE DAMAGE WERE REDUCED THE THERAPY WAS WELL TOLERATED WITH NO ADVERSE FINDINGS OBSERVED DURING THE STUDY CLINICAL SIGNIFICANCE DMD IS A PROGRESSIVE AND ULTIMATELY FATAL NEUROMUSCULAR DISORDER CHARACTERIZED BY ONGOING MUSCLE DEGENERATION, INFLAMMATION, AND FIBROSIS.

ATOSSA THERAPEUTICS PRESENTS CLINICAL TRIAL UPDATE HIGHLIGHTING (Z)-ENDOXIFEN RESEARCH AT THE 2026 MDA CLINICAL & SCIENTIFIC CONFERENCE

UNSOLD LISTINGS MAKE UP A GROWING SHARE OF THE RENTAL MARKET - THE SECOND-LARGEST ON RECORD AND TRENDING UPWARD 2.3% OF HOMES LISTED FOR RENT ON ZILLOW WERE

Zillow Group, Inc.

Z

Price

Financial Reports

No items found.

Press Releases

Zillow Group, Inc.

Z.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

Z